A Comprehensive Analysis of the Comparative Efficacy of Multimodal Diarrhea Therapies in the Paediatric Population

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 15, 2024

Primary Completion Date

December 15, 2024

Study Completion Date

December 30, 2024

Conditions
To Assess the Mean Time of Resolution of Diarrhea
Interventions
DRUG

Prebiotic

. The primary outcome measure will be the mean time from the initiation of treatment to the resolution of diarrhea symptoms. This objective seeks to provide evidence-based insights into the optimal management strategies for childhood diarrhea and inform clinical practice guidelines.

OTHER

Duration

every participant is alloted a group based on RCT.

DRUG

Smecta

Group 4 will be given smecta scahet

All Listed Sponsors
collaborator

Saglik Bilimleri Universitesi

OTHER

lead

Combined Military Hospital Multan

OTHER

NCT06588036 - A Comprehensive Analysis of the Comparative Efficacy of Multimodal Diarrhea Therapies in the Paediatric Population | Biotech Hunter | Biotech Hunter